Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
Impact of erythropoietin on the reduction of blood transfusions and on survival of lung cancer patients receiving first-line chemotherapyP J Fonseca, E Esteban, P de Vicente, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Phase II trial of bleomycin in patients with advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group StudyJ B Vermorken, J P Armand, A J Lacave, et al.
Breast Cancer Research and Treatment|February 16, 2000
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancerE Estaban, A J Lacave, J L Fernández, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group studyJ B Vermorken, G Zanetta, C F De Oliveira, et al.
The New England Journal of Medicine|March 9, 1995
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of CancerM E van der Burg, M van Lent, M Buyse, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group StudyC F de Oliveira, A J Lacave, C Villani, et al.
Cancer Treatment Reports|May 1, 1979
Iron toxicity studies of quelamycinA Brugarolas, J A Perez Llanderal, M T Garcia Miralles, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyE Esteban, L González de Sande, Y Fernández, et al.
Breast Cancer Research and Treatment|October 4, 2000
A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancerE Esteban, G de Sande, J Puertas, et al.
Pageof 4